|4May 19, 5:16 PM ET

Dickinson Klara 4

4 · CymaBay Therapeutics, Inc. · Filed May 19, 2020

Insider Transaction Report

Form 4
Period: 2020-05-15
Dickinson Klara
SVP, Regulatory Affairs & QA
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-05-15+328,299328,299 total
    Exercise: $4.05Exp: 2030-05-14Common Stock (328,299 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest in 48 equal monthly installments commencing on January 31, 2020, subject to the Reporting Person's continuous service to the Issuer as of each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION